The breadth of our research helps us address the unique needs of South Texas and the nation’s most pressing cancer concerns.
We are the only National Cancer Institute (NCI)-designated cancer center in Central and South Texas. This recognition of our research excellence places us among a select group across the country. Find out more about NCI designation.
Clinical trials for children and adults with cancer
Our clinical trials are exploring new methods of preventing, detecting, treating and surviving cancer. We participate in some of the nation’s most respected clinical trial networks. We take part in groups sponsored by NCI and the National Cancer Institute Clinical Oncology Group (NCORP).
These efforts give eligible pediatric and adult patients access to leading care options, often years before they become widely available.
Find out more about:
- Cancer clinical trials and research for adults
- Pediatric clinical trials and research
Our cancer research programs
Mays Cancer Center physician-scientists are reducing the impact of cancer in South Texas through focused research programs. Our holistic approach also includes sharing expert knowledge with future cancer researchers. Explore our cancer research programs.
Highlights of these efforts include:
- Basic research that’s yielding impactful discoveries about pediatric and adult cancer growth and progression
- Drug development, including novel drugs and new uses for existing drugs
- Outreach efforts to increase cancer screening rates and help more people in our community benefit from new care methods
- Engagement and training for emerging scientific leaders, from high school students through junior UT Health San Antonio faculty
Clinical trials at MD Anderson Cancer Center
Our partnership with MD Anderson Cancer Center gives eligible patients access to additional clinical trials.
Some trials are only available at MD Anderson Cancer Center. If you choose to participate in one of these trials, we share care information, as appropriate, with their team. This exchange may reduce the need for further tests or exams before starting the trial.
Find out more about our partnership with MD Anderson Cancer Center.